SECsense Logo

Cumberland Pharmaceuticals Inc. 8-K Report: Key Updates Revealed!

$CPIX
Form 8-K
Filed on: 2025-02-14
Source
Cumberland Pharmaceuticals Inc. 8-K Report: Key Updates Revealed!

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: Cumberland Pharmaceuticals Inc.
  • Location: 1600 West End Avenue, Suite 1300, Nashville, TN 37203
  • Phone: 615-255-0068
  • CIK: 0001087294
  • SEC File Number: 001-33637
  • EIN: 62-1765329
  1. Document Type:
  • Filing Type: 8-K (Current Report)
  1. Filing Date:
  • Date of Report: February 14, 2025
  1. Stock Information:
  • Common Stock: No par value
  • Ticker Symbol: CPIX
  • Exchange: NASDAQ
  1. Period of Reporting:
  • Report Start Date: February 14, 2025
  • Report End Date: February 14, 2025
  1. XBRL Information:
  • The document is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for SEC filings to enhance data accessibility and analysis.

Insights:

  • This report is an 8-K filing, which typically indicates that the company is reporting significant events or changes that shareholders should be aware of.
  • The reporting period is for a single day, suggesting that the information may pertain to a specific event or transaction that occurred on February 14, 2025.
  • The company is listed on the NASDAQ under the ticker CPIX, indicating it is publicly traded and subject to SEC regulations.

This summary provides a snapshot of Cumberland Pharmaceuticals Inc.'s essential details as of the filing date, which may be relevant for investors, analysts, and stakeholders.